Product
Our Product: MyopiaX®
MyopiaX® is an application for smartphones that provides a treatment to slow the progression of myopia in children and adolescents. Used together with a virtual reality headset and a Bluetooth controller, MyopiaX® is an innovative, non-invasive method to control myopia that is portable, fun, and easy for children to use.
Use the MyopiaX® app to start a session, keep track of usage and performance to optimize treatment, customize daily availability, and much more. Each session with MyopiaX® delivers a light stimulus on top of the virtual reality game. The goal is to increase dopamine levels in the retina to slow the progression of myopia. Learn more about how MyopiaX® works on our Science page.
Our App
MyopiaX® has been designed specifically for children, providing a fun and exciting treatment while adhering to medical device regulations. Treatment requires only two short sessions per day, making it easy to integrate MyopiaX® into existing daily routines. Performance and adherence logging in the app help ensure that all sessions are being completed. A usability study with children and their families confirmed that MyopiaX® is intuitive, fun, and easy for children to use under minimal supervision.
Designed with Children in Mind
MyopiaX® has been developed to deliver a medical effect while children play games or use educational content. Each step in the development of MyopiaX® has involved children and their families. We used the feedback from usability studies to ensure that MyopiaX® is appropriately tailored to children. Our extensive usability engineering studies exceed the standard requirements to evaluate the usability of a medical device as it relates to safety and have been central to the continuous improvement of technical components of the app, as well as the overall user experience of MyopiaX®.
Developed According to Medical Device Standards
MyopiaX® has been designed and developed in accordance with medical device standards of safety related to everyday use. MyopiaX® is accompanied by comprehensive technical documentation that takes into consideration all relevant norms, including those for software lifecycle management (EN 62304) and risk management (ISO 14971). Our goal is to be certified as a class IIa medical device under the EU medical device regulation (MDR). The results of our ongoing clinical trial will inform future activities to obtain certification of MyopiaX® as a medical device under the MDR.
More About MyopiaX®
MyopiaX® is designed to be used twice a day. Each session lasts for several minutes and delivers a therapeutic light stimulus while a virtual reality game is played. The virtual reality game includes mini-games, a customizable avatar, and interactive quests. A variety of game content means that MyopiaX® is always fun to use.
Our Partners
Dopavision is funded as part of the BMBF’s Industry-in-Clinic Platform Program (FKZ: 13GW0625)